Cargando…

Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy

Exosomes are naturally occurring nanosized particles that aid intercellular communication by transmitting biological information between cells. Exosomes have therapeutic efficacy that can transfer their contents between cells as natural carriers. In addition, the exosomal contents delivered to the r...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussen, Bashdar Mahmud, Faraj, Goran Sedeeq Hama, Rasul, Mohammad Fatih, Hidayat, Hazha Jamal, Salihi, Abbas, Baniahmad, Aria, Taheri, Mohammad, Ghafouri-Frad, Soudeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580186/
https://www.ncbi.nlm.nih.gov/pubmed/36258195
http://dx.doi.org/10.1186/s12935-022-02743-3
_version_ 1784812336791420928
author Hussen, Bashdar Mahmud
Faraj, Goran Sedeeq Hama
Rasul, Mohammad Fatih
Hidayat, Hazha Jamal
Salihi, Abbas
Baniahmad, Aria
Taheri, Mohammad
Ghafouri-Frad, Soudeh
author_facet Hussen, Bashdar Mahmud
Faraj, Goran Sedeeq Hama
Rasul, Mohammad Fatih
Hidayat, Hazha Jamal
Salihi, Abbas
Baniahmad, Aria
Taheri, Mohammad
Ghafouri-Frad, Soudeh
author_sort Hussen, Bashdar Mahmud
collection PubMed
description Exosomes are naturally occurring nanosized particles that aid intercellular communication by transmitting biological information between cells. Exosomes have therapeutic efficacy that can transfer their contents between cells as natural carriers. In addition, the exosomal contents delivered to the recipient pathological cells significantly inhibit cancer progression. However, exosome-based tumor treatments are inadequately precise or successful, and various challenges should be adequately overcome. Here, we discuss the significant challenges that exosomes face as drug carriers used for therapeutic targets and strategies for overcoming these challenges in order to promote this new incoming drug carrier further and improve future clinical outcomes. We also present techniques for overcoming these challenges.
format Online
Article
Text
id pubmed-9580186
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95801862022-10-20 Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy Hussen, Bashdar Mahmud Faraj, Goran Sedeeq Hama Rasul, Mohammad Fatih Hidayat, Hazha Jamal Salihi, Abbas Baniahmad, Aria Taheri, Mohammad Ghafouri-Frad, Soudeh Cancer Cell Int Review Exosomes are naturally occurring nanosized particles that aid intercellular communication by transmitting biological information between cells. Exosomes have therapeutic efficacy that can transfer their contents between cells as natural carriers. In addition, the exosomal contents delivered to the recipient pathological cells significantly inhibit cancer progression. However, exosome-based tumor treatments are inadequately precise or successful, and various challenges should be adequately overcome. Here, we discuss the significant challenges that exosomes face as drug carriers used for therapeutic targets and strategies for overcoming these challenges in order to promote this new incoming drug carrier further and improve future clinical outcomes. We also present techniques for overcoming these challenges. BioMed Central 2022-10-18 /pmc/articles/PMC9580186/ /pubmed/36258195 http://dx.doi.org/10.1186/s12935-022-02743-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Hussen, Bashdar Mahmud
Faraj, Goran Sedeeq Hama
Rasul, Mohammad Fatih
Hidayat, Hazha Jamal
Salihi, Abbas
Baniahmad, Aria
Taheri, Mohammad
Ghafouri-Frad, Soudeh
Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy
title Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy
title_full Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy
title_fullStr Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy
title_full_unstemmed Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy
title_short Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy
title_sort strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580186/
https://www.ncbi.nlm.nih.gov/pubmed/36258195
http://dx.doi.org/10.1186/s12935-022-02743-3
work_keys_str_mv AT hussenbashdarmahmud strategiestoovercomethemainchallengesoftheuseofexosomesasdrugcarrierforcancertherapy
AT farajgoransedeeqhama strategiestoovercomethemainchallengesoftheuseofexosomesasdrugcarrierforcancertherapy
AT rasulmohammadfatih strategiestoovercomethemainchallengesoftheuseofexosomesasdrugcarrierforcancertherapy
AT hidayathazhajamal strategiestoovercomethemainchallengesoftheuseofexosomesasdrugcarrierforcancertherapy
AT salihiabbas strategiestoovercomethemainchallengesoftheuseofexosomesasdrugcarrierforcancertherapy
AT baniahmadaria strategiestoovercomethemainchallengesoftheuseofexosomesasdrugcarrierforcancertherapy
AT taherimohammad strategiestoovercomethemainchallengesoftheuseofexosomesasdrugcarrierforcancertherapy
AT ghafourifradsoudeh strategiestoovercomethemainchallengesoftheuseofexosomesasdrugcarrierforcancertherapy